Comparative Neuromuscular Diseases Laboratory, Department of Clinical Sciences and Services, Royal Veterinary College, London NW1 0TU, United Kingdom.
Queen Mother Hospital for Animals, Department of Clinical Sciences and Services, Royal Veterinary College, Hatfield AL9 7TA, United Kingdom.
Neuromuscul Disord. 2021 Aug;31(8):736-751. doi: 10.1016/j.nmd.2021.05.010. Epub 2021 Jun 2.
The DE50-MD canine model of Duchenne muscular dystrophy (DMD) has a dystrophin gene splice site mutation causing deletion of exon 50, an out-of-frame transcript and absence of dystrophin expression in striated muscles. We hypothesized that the musculoskeletal phenotype of DE50-MD dogs could be detected using Magnetic Resonance Imaging (MRI), that it would progress with age and that it would reflect those in other canine models and DMD patients. 15 DE50-MD and 10 age-matched littermate wild type (WT) male dogs underwent MRI every 3 months from 3 to 18 months of age. Normalized muscle volumes, global muscle T2 and ratio of post- to pre-gadolinium T1-weighted SI were evaluated in 7 pelvic limb and 4 lumbar muscles bilaterally. DE50-MD dogs, compared to WT, had smaller volumes in all muscles, except the cranial sartorius; global muscle T2 was significantly higher in DE50-MD dogs compared to WT. Muscle volumes plateaued and global muscle T2 decreased with age. Normalized muscle volumes and global muscle T2 revealed significant differences between groups longitudinally and should be useful to determine efficacy of therapeutics in this model with suitable power and low sample sizes. Musculoskeletal changes reflect those of DMD patients and other dog models.
DE50-MD 犬杜氏肌营养不良症(DMD)模型存在肌营养不良蛋白基因剪接位点突变,导致外显子 50 缺失、无框架转录本和横纹肌中肌营养不良蛋白表达缺失。我们假设 DE50-MD 犬的肌肉骨骼表型可以通过磁共振成像(MRI)检测到,其会随年龄增长而进展,并反映在其他犬模型和 DMD 患者中。15 只 DE50-MD 和 10 只年龄匹配的野生型(WT)雄性犬从 3 个月到 18 个月龄每隔 3 个月接受一次 MRI 检查。在双侧 7 个骨盆肢肌和 4 个腰椎肌中评估了正常化肌肉体积、全局肌肉 T2 和钆后与预钆 T1 加权 SI 比。与 WT 相比,DE50-MD 犬除了颅部缝匠肌外,所有肌肉的体积都较小;DE50-MD 犬的全局肌肉 T2 明显高于 WT。肌肉体积随年龄增长而趋于平稳,全局肌肉 T2 随年龄增长而降低。正常化肌肉体积和全局肌肉 T2 在纵向显示出组间的显著差异,应该有助于在该模型中确定治疗药物的疗效,具有适当的功效和小样本量。肌肉骨骼变化反映了 DMD 患者和其他犬模型的变化。